Full Text
The Full Text of this article is available as a PDF (42.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cochrane A. L., Holland W. W. Validation of screening procedures. Br Med Bull. 1971 Jan;27(1):3–8. doi: 10.1093/oxfordjournals.bmb.a070810. [DOI] [PubMed] [Google Scholar]
- Gøtzsche P. C., Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000 Jan 8;355(9198):129–134. doi: 10.1016/S0140-6736(99)06065-1. [DOI] [PubMed] [Google Scholar]
- Sackett D. L., Holland W. W. Controversy in the detection of disease. Lancet. 1975 Aug 23;2(7930):357–359. doi: 10.1016/s0140-6736(75)92790-7. [DOI] [PubMed] [Google Scholar]
- Tanenbaum S. J. "Medical effectiveness" in Canadian and U.S. health policy: the comparative politics of inferential ambiguity. Health Serv Res. 1996 Dec;31(5):517–532. [PMC free article] [PubMed] [Google Scholar]
- Wald N. J., Rodeck C., Hackshaw A. K., Walters J., Chitty L., Mackinson A. M., SURUSS Research Group First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess. 2003;7(11):1–77. doi: 10.3310/hta7110. [DOI] [PubMed] [Google Scholar]